Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.51 billion.

GUIDANCE:

Agilon Health Inc. sees Q1 2025 revenue of $1.48-1.52 billion, versus the consensus of $1.69 billion.

Agilon Health Inc. sees FY2025 revenue of $5.82-6.02 billion, versus the consensus of $6.61 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.